Developer docs
API playgroundTry for free, no card

Search company profiles

LyoWave

Full company profile

uuid00278k3

Namestring
LyoWave
Legal namestring
LyoWave Inc.
Websiteurl
lyowave.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

LyoWave Inc. is a West Lafayette, Indiana-based spin-off from Purdue University, founded in 2023 to commercialize high-frequency microwave/RF heating technology for pharmaceutical freeze-drying (lyophilization) and thawing. The company operates a tunable RF platform that operates at 12-18 GHz — compared with the 2.45 GHz used in conventional microwave systems — specifically targeting the dielectric properties of water ice to deliver more uniform and faster heating. Its proprietary electromagnetic mixing via metasurface scattering reportedly achieves more than 5x greater electric field uniformity than traditional systems, and closed-loop optical and infrared temperature sensing enable precise product temperature control during drying and thawing. Core technology is exclusively licensed from Purdue Innovates Office of Technology Commercialization, originating from research that began in 2016 by founders Alina Alexeenko and Dimitrios Peroulis.

LyoWave sells three branded products: TurboDry™ (the core freeze-drying heating platform), TurboThaw™ (controlled-rate microwave thawing for bulk frozen API), and LyoVision™ (a real-time infrared thermal imaging system). All three are modular and retrofittable onto existing laboratory, pilot, and production-scale freeze-dryers, including Millrock Technology's REVO platform under a 2024 channel and integration agreement. The company also offers testing services (RF-assisted lyophilization, RF-assisted thawing, and dielectric property characterization) with fees credited toward subsequent hardware purchases, functioning as a customer acquisition funnel. Customers are pharmaceutical and biopharmaceutical manufacturers processing injectables, vaccines, biologics, mAbs, cell therapies, and diagnostic reagents, with co-development relationships with Merck and IMA Life extending reach into commercial sterile fill-finish and vaccine supply chains.

The business model combines direct enterprise hardware sales with a Millrock Technology OEM/reseller channel and grant-funded R&D (NSF SBIR Phase I of $304,436 plus $50,000 Indiana EDC matching, a $25,000 Trask Innovation Fund award, and a nearly $1 million NIIMBL/Gates Foundation award to Purdue researchers advancing the underlying lyophilization science). The company is privately held and pre-commercial, having received an undisclosed seed round from Handshake Ventures and operating with 1-10 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWest Lafayette, United States
HQ citystring
West Lafayette
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical freeze-drying, microwave lyophilization equipment, biologics manufacturing technology, freeze dryer retrofit systems, controlled thaw platforms
Industry3 codes
PRIMARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code2 codes
  • Heating Equipment (except Warm Air Furnaces) Manufacturing333414
  • Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing3334
SIC code2 codes
  • Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip3585
  • Services-Testing Laboratories8734
Product category
Pharmaceutical Freeze-Drying Equipment
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Hardware Product Sales
TypeHardware Sales
Description

Sale of proprietary microwave heating hardware platforms including TurboDry (freeze-drying), TurboThaw (thawing), and LyoVision (thermal imaging) systems. Products are sold as capital equipment to pharmaceutical manufacturers with pricing quoted based on configuration and scale.

lyowave.com
2Testing Services
TypeProfessional Services
Description

LyoWave offers testing services where customers ship frozen API or bulk drug substance to their facility. The company runs the freeze-drying or thawing process and returns full cycle data alongside the processed material. Testing fees are credited toward subsequent product purchases.

lyowave.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Pricing details1 tier
1Testing Services
ModelOtherBilling cadencePay-as-you-go
Notes

Testing fee is credited toward any subsequent purchase of TurboDry, TurboThaw, or LyoVision products.

lyowave.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1TurboDry™
Description

Tunable high-frequency microwave heating platform for pharmaceutical freeze-drying. Accelerates manufacturing process for frozen and lyophilized pharmaceutical systems using solid-state RF amplifier technology.

lyowave.com
+2 more records
Core offering1 text field

LyoWave designs, develops, and sells capital equipment and testing services that use patented high-frequency microwave/RF heating (operating at 12–18 GHz) to accelerate pharmaceutical freeze-drying (lyophilization) and bulk-API thawing. Its flagship hardware platforms — TurboDry™ for lyophilization, TurboThaw™ for controlled thawing, and LyoVision™ for real-time IR thermal imaging — are sold to pharmaceutical and biopharmaceutical manufacturers and are retrofittable onto existing freeze-drying systems. The company also offers fee-for-service RF-assisted lyophilization, thawing, and dielectric property characterization testing that converts into product sales.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 2-5x faster freeze-drying process compared to conventional methods
+3 more records
Product overview1 text field

LyoWave offers a three-product technology suite for pharmaceutical freeze-drying and thawing: TurboDry™ is the core tunable high-frequency microwave/RF heating platform for accelerating lyophilization and enabling novel dosage forms; TurboThaw™ is a controlled-rate microwave thawing system for bulk frozen API that reduces thawing time by up to 4x; and LyoVision™ is a real-time infrared thermal imaging system providing non-invasive, spatially-resolved temperature monitoring with native closed-loop integration into both TurboDry™ and TurboThaw™. The products share a common high-frequency microwave technology foundation (operating above 8 GHz), a unified closed-loop optical temperature sensing architecture, and are collectively branded as LyoWave's 'Thermal Processing Technology Suite.' All three products are retrofittable to existing freeze-drying systems, including Millrock Technology's REVO platform. LyoWave also offers fee-for-service testing — dielectric property characterization, RF-assisted lyophilization assessment, and RF-assisted thawing assessment — with testing fees credited toward product purchases.

Product and service6 records
1TurboDry™
CategoryPharmaceutical freeze-drying (lyophilization) equipment
Description

Tunable high-frequency microwave/RF heating platform for pharmaceutical freeze-drying. Operates above 8 GHz to target water ice, uses proprietary electromagnetic mixing and metasurface scattering for >5x greater electric field uniformity than 2.45 GHz systems, and is retrofittable onto new and existing laboratory and pilot-scale freeze-drying systems in minutes. Achieves >1.5–2x speedup for conventional vials and >5x speedup for bulk materials and lyobeads. Sold to pharmaceutical manufacturers as capital equipment.

2TurboThaw™
CategoryBiologics thawing equipment
Description

Controlled-rate microwave thawing platform for bulk frozen API and biologics. Reduces thawing time by up to 4x versus conventional ambient methods while preserving critical quality attributes for biologics, mAbs, and cell therapies. Operates at ~13–15 GHz with 30W or 60W power modules, is compatible with primary packaging from 30mL to 4L, and features closed-loop optical temperature sensing with native LyoVision IR imaging compatibility.

3LyoVision™
CategoryProcess analytical technology / thermal imaging instrumentation
Description

Real-time infrared thermal imaging system for freeze-drying and thawing. Provides non-invasive, spatially-resolved product temperature measurements using a 320x256 pixel IR sensor with 30mK thermal sensitivity and ±2°C accuracy down to -40°C. Available in 34°, 52°, and 90° fields of view. Natively integrates with TurboDry and TurboThaw for closed-loop IR-guided product temperature control, is CIP/SIP compatible, and mounts to any 3" sanitary port via a single 48V PoE Ethernet cable.

4RF-Assisted Lyophilization Testing Service
CategoryTesting / contract research services
Description

Fee-for-service testing in which LyoWave processes customer-supplied frozen API or bulk drug substance using its RF heating platform and returns complete cycle data alongside the processed material. Includes freeze-drying speedup assessment and dielectric property characterization. Testing fee is credited toward subsequent purchase of TurboDry, TurboThaw, or LyoVision products.

5RF-Assisted Thawing Testing Service
CategoryTesting / contract research services
Description

Fee-for-service testing in which LyoWave processes customer-supplied frozen or liquid bulk API and biologics using its RF-assisted thawing platform and returns complete cycle data alongside the processed material. Includes thawing speedup assessment and temperature uniformity characterization. Testing fee is credited toward subsequent purchase of TurboDry, TurboThaw, or LyoVision products.

6Dielectric Property Characterization Service
CategoryTesting / contract research services
Description

Material-level RF property testing for frozen and liquid pharmaceutical formulations, including S-parameters and complex permittivity assessment at -25°C and 50°C with loss factor sensitivity of 0.1–30. Testing fee is credited toward subsequent purchase of TurboDry, TurboThaw, or LyoVision products.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-05-07
Description

LyoWave entered into a collaboration agreement with Millrock Technology, an industry leader in innovative freeze dryers for biotech, pharmaceutical and industrial applications. Millrock will offer LyoWave's system for its already installed and new freeze dryers, starting with their popular REVO model. The LyoWave system implements microwave heating for current freeze dryers, allowing users to increase throughput with minimal changes to existing installations. LyoWave has partnered with Millrock to bring a limited number of microwave sources to REVO freeze-drying systems for development purposes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

LyoWave was founded by researchers at Purdue University's College of Engineering. The company licenses patented and patent-pending technologies through the Purdue Innovates Office of Technology Commercialization. LyoWave's founders have been jointly leading the team of Purdue researchers who developed the innovations since 2016.

3LyoHUB
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LyoHUB is a university-industry center at Purdue University co-founded by Alina Alexeenko in 2014, focused on advancing the science and technology of lyophilization. LyoWave works with LyoHUB for early testing by industry on real products. The center has grown to include 32 member companies and developed the first recognized consensus standard in lyophilization instrumentation issued by ASTM in 2021.

lyowave.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Merck partnered with Purdue on the microwave lyophilization project, providing vaccine samples and leading development of benchmarks to compare conventional and microwave lyophilization processes.

5IMA Life North America Inc.
Strategic tierMajorTypeStrategic or Co-development Partner
Description

IMA Life partnered with Purdue on the microwave project, leading integration of the new technology with the entire manufacturing process for sterile pharmaceuticals and vaccines. IMA Life CEO noted the technology promises to provide uniformity and accelerate the freeze-drying process.

lyowave.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

U.S. manufacturer of laboratory freeze dryers (FreeZone line) widely used in pharma R&D and academic labs. Competitor for the laboratory-scale lyophilization equipment segment that LyoWave addresses with its TurboDry modular retrofit.

TypeBroad incumbent
Description

Large German engineering group with a substantial pharmaceutical processing portfolio including lyophilization, aseptic, and separation equipment. A broad incumbent that includes LyoWave's competitive set among a much larger capital-equipment offering.

TypeDirect peer
Description

German specialist manufacturer of laboratory, pilot, and production-scale freeze dryers (Alpha, Epsilon, and Pilot lines). Directly comparable as a lyophilization equipment peer across the lab-to-production scale LyoWave targets.

4Hosokawa Micron Group
TypeBroad incumbent
Description

Japanese-led process equipment group with powder/particle and drying technologies relevant to bulk pharmaceutical processing. A broader incumbent that overlaps with LyoWave at the bulk material and powder freeze-drying applications (e.g., spray-frozen lyobeads).

5BÜCHI Labortechnik AG
TypeDirect peer
Description

Swiss lab and pilot-scale freeze dryer manufacturer with the Lyovapor and Lyovision systems. Comparable to LyoWave in lab/pilot lyophilization equipment and serves overlapping pharmaceutical R&D customers.

TypeBroad incumbent
Description

Diversified life-sciences and pharma services giant with scientific equipment and CDMO capabilities touching the lyophilization workflow (Patheon CDMO services, lab equipment). A broad incumbent with overlapping customer relationships but a much wider portfolio than LyoWave's.

7Telstar (Azbil Corporation)
TypeDirect peer
Description

Pharmaceutical freeze-drying, sterilisation, and aseptic processing equipment brand within Azbil Corporation. Provides integrated lyophilization solutions to pharma manufacturers and is a comparable vendor at the production scale LyoWave is targeting.

TypeDirect peer
Description

Long-established lyophilization equipment manufacturer (VirTis, Hull, FTS, and PennTech product lines) serving pharma and biotech. Directly competes for the same capital budget in pharmaceutical freeze-drying equipment and serves the same regulated end-market as LyoWave.

TypeDirect peer
Description

Italian manufacturer of sterile pharmaceutical processing and packaging equipment including freeze-drying solutions. IMA Life is an active development partner with Purdue/LyoWave on integrating the microwave technology into sterile fill-finish lines, and a direct competitor for lyophilization capex.

TypeDirect peer
Description

Industry-leading freeze dryer manufacturer with a popular REVO platform. LyoWave partners with Millrock to integrate its microwave heating sources into Millrock's installed base and new units; both serve pharmaceutical lyophilization customers with complementary hardware positions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LyoWave

Pharmaceutical Freeze-Drying Equipmentlyowave.com

What LyoWave does

LyoWave Inc. is a West Lafayette, Indiana-based spin-off from Purdue University, founded in 2023 to commercialize high-frequency microwave/RF heating technology for pharmaceutical freeze-drying (lyophilization) and thawing. The company operates a tunable RF platform that operates at 12-18 GHz — compared with the 2.45 GHz used in conventional microwave systems — specifically targeting the dielectric properties of water ice to deliver more uniform and faster heating. Its proprietary electromagnetic mixing via metasurface scattering reportedly achieves more than 5x greater electric field uniformity than traditional systems, and closed-loop optical and infrared temperature sensing enable precise product temperature control during drying and thawing. Core technology is exclusively licensed from Purdue Innovates Office of Technology Commercialization, originating from research that began in 2016 by founders Alina Alexeenko and Dimitrios Peroulis.

LyoWave sells three branded products: TurboDry™ (the core freeze-drying heating platform), TurboThaw™ (controlled-rate microwave thawing for bulk frozen API), and LyoVision™ (a real-time infrared thermal imaging system). All three are modular and retrofittable onto existing laboratory, pilot, and production-scale freeze-dryers, including Millrock Technology's REVO platform under a 2024 channel and integration agreement. The company also offers testing services (RF-assisted lyophilization, RF-assisted thawing, and dielectric property characterization) with fees credited toward subsequent hardware purchases, functioning as a customer acquisition funnel. Customers are pharmaceutical and biopharmaceutical manufacturers processing injectables, vaccines, biologics, mAbs, cell therapies, and diagnostic reagents, with co-development relationships with Merck and IMA Life extending reach into commercial sterile fill-finish and vaccine supply chains.

The business model combines direct enterprise hardware sales with a Millrock Technology OEM/reseller channel and grant-funded R&D (NSF SBIR Phase I of $304,436 plus $50,000 Indiana EDC matching, a $25,000 Trask Innovation Fund award, and a nearly $1 million NIIMBL/Gates Foundation award to Purdue researchers advancing the underlying lyophilization science). The company is privately held and pre-commercial, having received an undisclosed seed round from Handshake Ventures and operating with 1-10 employees.

LyoWave firmographics

Firmographics
Name
LyoWave
Legal name
LyoWave Inc.
Website
https://lyowave.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

LyoWave industry classification

Industry
Product category
Pharmaceutical Freeze-Drying Equipment
NAICS
Heating Equipment (except Warm Air Furnaces) Manufacturing (333414), Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing (3334)
SIC
Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

  • Pharmaceutical freeze-drying
  • Microwave lyophilization equipment
  • Biologics manufacturing technology
  • Freeze dryer retrofit systems
  • Controlled thaw platforms

Where LyoWave is headquartered

Location

Headquarters

HQ city
West Lafayette
HQ country
United States
HQ region
North America

Markets served

LyoWave business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

  1. Hardware Product Sales: Sale of proprietary microwave heating hardware platforms including TurboDry (freeze-drying), TurboThaw (thawing), and LyoVision (thermal imaging) systems. Products are sold as capital equipment to pharmaceutical manufacturers with pricing quoted based on configuration and scale.
  2. Testing Services: LyoWave offers testing services where customers ship frozen API or bulk drug substance to their facility. The company runs the freeze-drying or thawing process and returns full cycle data alongside the processed material. Testing fees are credited toward subsequent product purchases.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goTesting Services

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

LyoWave product offering

Product offering

Core offering

LyoWave designs, develops, and sells capital equipment and testing services that use patented high-frequency microwave/RF heating (operating at 12–18 GHz) to accelerate pharmaceutical freeze-drying (lyophilization) and bulk-API thawing. Its flagship hardware platforms — TurboDry™ for lyophilization, TurboThaw™ for controlled thawing, and LyoVision™ for real-time IR thermal imaging — are sold to pharmaceutical and biopharmaceutical manufacturers and are retrofittable onto existing freeze-drying systems. The company also offers fee-for-service RF-assisted lyophilization, thawing, and dielectric property characterization testing that converts into product sales.

Product overview

LyoWave offers a three-product technology suite for pharmaceutical freeze-drying and thawing: TurboDry™ is the core tunable high-frequency microwave/RF heating platform for accelerating lyophilization and enabling novel dosage forms; TurboThaw™ is a controlled-rate microwave thawing system for bulk frozen API that reduces thawing time by up to 4x; and LyoVision™ is a real-time infrared thermal imaging system providing non-invasive, spatially-resolved temperature monitoring with native closed-loop integration into both TurboDry™ and TurboThaw™. The products share a common high-frequency microwave technology foundation (operating above 8 GHz), a unified closed-loop optical temperature sensing architecture, and are collectively branded as LyoWave's 'Thermal Processing Technology Suite.' All three products are retrofittable to existing freeze-drying systems, including Millrock Technology's REVO platform. LyoWave also offers fee-for-service testing — dielectric property characterization, RF-assisted lyophilization assessment, and RF-assisted thawing assessment — with testing fees credited toward product purchases.

Differentiator

Problem solved

Functional benefit

Brands

  • TurboDry™: Tunable high-frequency microwave heating platform for pharmaceutical freeze-drying. Accelerates manufacturing process for frozen and lyophilized pharmaceutical systems using solid-state RF amplifier technology.
  • TurboThaw™
  • LyoVision™

Products and services

  • TurboDry™ Tunable high-frequency microwave/RF heating platform for pharmaceutical freeze-drying. Operates above 8 GHz to target water ice, uses proprietary electromagnetic mixing and metasurface scattering for >5x greater electric field uniformity than 2.45 GHz systems, and is retrofittable onto new and existing laboratory and pilot-scale freeze-drying systems in minutes. Achieves >1.5–2x speedup for conventional vials and >5x speedup for bulk materials and lyobeads. Sold to pharmaceutical manufacturers as capital equipment.
  • TurboThaw™ Controlled-rate microwave thawing platform for bulk frozen API and biologics. Reduces thawing time by up to 4x versus conventional ambient methods while preserving critical quality attributes for biologics, mAbs, and cell therapies. Operates at ~13–15 GHz with 30W or 60W power modules, is compatible with primary packaging from 30mL to 4L, and features closed-loop optical temperature sensing with native LyoVision IR imaging compatibility.
  • LyoVision™ Real-time infrared thermal imaging system for freeze-drying and thawing. Provides non-invasive, spatially-resolved product temperature measurements using a 320x256 pixel IR sensor with 30mK thermal sensitivity and ±2°C accuracy down to -40°C. Available in 34°, 52°, and 90° fields of view. Natively integrates with TurboDry and TurboThaw for closed-loop IR-guided product temperature control, is CIP/SIP compatible, and mounts to any 3" sanitary port via a single 48V PoE Ethernet cable.
  • RF-Assisted Lyophilization Testing Service Fee-for-service testing in which LyoWave processes customer-supplied frozen API or bulk drug substance using its RF heating platform and returns complete cycle data alongside the processed material. Includes freeze-drying speedup assessment and dielectric property characterization. Testing fee is credited toward subsequent purchase of TurboDry, TurboThaw, or LyoVision products.
  • RF-Assisted Thawing Testing Service Fee-for-service testing in which LyoWave processes customer-supplied frozen or liquid bulk API and biologics using its RF-assisted thawing platform and returns complete cycle data alongside the processed material. Includes thawing speedup assessment and temperature uniformity characterization. Testing fee is credited toward subsequent purchase of TurboDry, TurboThaw, or LyoVision products.
  • Dielectric Property Characterization Service Material-level RF property testing for frozen and liquid pharmaceutical formulations, including S-parameters and complex permittivity assessment at -25°C and 50°C with loss factor sensitivity of 0.1–30. Testing fee is credited toward subsequent purchase of TurboDry, TurboThaw, or LyoVision products.

Quantifiable outcome

  • 2-5x faster freeze-drying process compared to conventional methods
  • +3 more outcomes

Companies that use LyoWave

Customer profile

Segments3 records

Ideal customer profiles2 records

LyoWave technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

LyoWave partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and major.

  • Millrock TechnologycoreTechnology or Integration · 7 May 2024LyoWave entered into a collaboration agreement with Millrock Technology, an industry leader in innovative freeze dryers for biotech, pharmaceutical and industrial applications. Millrock will offer LyoWave's system for its already installed and new freeze dryers, starting with their popular REVO model. The LyoWave system implements microwave heating for current freeze dryers, allowing users to increase throughput with minimal changes to existing installations. LyoWave has partnered with Millrock to bring a limited number of microwave sources to REVO freeze-drying systems for development purposes.
  • Purdue University / Purdue Innovates Office of Technology CommercializationcoreStrategic or Co-development PartnerLyoWave was founded by researchers at Purdue University's College of Engineering. The company licenses patented and patent-pending technologies through the Purdue Innovates Office of Technology Commercialization. LyoWave's founders have been jointly leading the team of Purdue researchers who developed the innovations since 2016.
  • LyoHUBcoreStrategic or Co-development PartnerLyoHUB is a university-industry center at Purdue University co-founded by Alina Alexeenko in 2014, focused on advancing the science and technology of lyophilization. LyoWave works with LyoHUB for early testing by industry on real products. The center has grown to include 32 member companies and developed the first recognized consensus standard in lyophilization instrumentation issued by ASTM in 2021.
  • MerckmajorStrategic or Co-development PartnerMerck partnered with Purdue on the microwave lyophilization project, providing vaccine samples and leading development of benchmarks to compare conventional and microwave lyophilization processes.
  • IMA Life North America Inc.majorStrategic or Co-development PartnerIMA Life partnered with Purdue on the microwave project, leading integration of the new technology with the entire manufacturing process for sterile pharmaceuticals and vaccines. IMA Life CEO noted the technology promises to provide uniformity and accelerate the freeze-drying process.

Scale indicators7 records

Recent moves9 records

Expansion highlights5 records

LyoWave competitors and assessment

Company assessment

Direct peers

  • Labconco Corporation: U.S. manufacturer of laboratory freeze dryers (FreeZone line) widely used in pharma R&D and academic labs. Competitor for the laboratory-scale lyophilization equipment segment that LyoWave addresses with its TurboDry modular retrofit.
  • Martin Christ Gefriertrocknungsanlagen GmbH: German specialist manufacturer of laboratory, pilot, and production-scale freeze dryers (Alpha, Epsilon, and Pilot lines). Directly comparable as a lyophilization equipment peer across the lab-to-production scale LyoWave targets.
  • BÜCHI Labortechnik AG: Swiss lab and pilot-scale freeze dryer manufacturer with the Lyovapor and Lyovision systems. Comparable to LyoWave in lab/pilot lyophilization equipment and serves overlapping pharmaceutical R&D customers.
  • Telstar (Azbil Corporation): Pharmaceutical freeze-drying, sterilisation, and aseptic processing equipment brand within Azbil Corporation. Provides integrated lyophilization solutions to pharma manufacturers and is a comparable vendor at the production scale LyoWave is targeting.
  • SP Scientific (SP Industries, ATS Corporation): Long-established lyophilization equipment manufacturer (VirTis, Hull, FTS, and PennTech product lines) serving pharma and biotech. Directly competes for the same capital budget in pharmaceutical freeze-drying equipment and serves the same regulated end-market as LyoWave.
  • IMA Life (IMA S.p.A.): Italian manufacturer of sterile pharmaceutical processing and packaging equipment including freeze-drying solutions. IMA Life is an active development partner with Purdue/LyoWave on integrating the microwave technology into sterile fill-finish lines, and a direct competitor for lyophilization capex.
  • Millrock Technology, Inc. Industry-leading freeze dryer manufacturer with a popular REVO platform. LyoWave partners with Millrock to integrate its microwave heating sources into Millrock's installed base and new units; both serve pharmaceutical lyophilization customers with complementary hardware positions.

Broad incumbents

  • GEA Group AG: Large German engineering group with a substantial pharmaceutical processing portfolio including lyophilization, aseptic, and separation equipment. A broad incumbent that includes LyoWave's competitive set among a much larger capital-equipment offering.
  • Hosokawa Micron Group: Japanese-led process equipment group with powder/particle and drying technologies relevant to bulk pharmaceutical processing. A broader incumbent that overlaps with LyoWave at the bulk material and powder freeze-drying applications (e.g., spray-frozen lyobeads).
  • Thermo Fisher Scientific Inc. Diversified life-sciences and pharma services giant with scientific equipment and CDMO capabilities touching the lyophilization workflow (Patheon CDMO services, lab equipment). A broad incumbent with overlapping customer relationships but a much wider portfolio than LyoWave's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

LyoWave social profiles

Digital presence

LyoWave financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LyoWave leadership team

Management profile

Number of profiles

Profiles7 records

LyoWave funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LyoWave M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LyoWave

What does LyoWave do?

LyoWave designs, develops, and sells capital equipment and testing services that use patented high-frequency microwave/RF heating (operating at 12–18 GHz) to accelerate pharmaceutical freeze-drying (lyophilization) and bulk-API thawing. Its flagship hardware platforms — TurboDry™ for lyophilization, TurboThaw™ for controlled thawing, and LyoVision™ for real-time IR thermal imaging — are sold to pharmaceutical and biopharmaceutical manufacturers and are retrofittable onto existing freeze-drying systems. The company also offers fee-for-service RF-assisted lyophilization, thawing, and dielectric property characterization testing that converts into product sales.

Is LyoWave a public or private company?

LyoWave is a private company. It is classified as venture growth investor backed and is currently operating.

When was LyoWave founded?

LyoWave was founded in 2023. It employs 1 to 10 people.

Where is LyoWave based?

LyoWave is headquartered in West Lafayette, United States, in the North America region.

How does LyoWave make money?

Two revenue lines are on record. Hardware Product Sales are the primary driver. The others are testing Services.

Who are LyoWave's main competitors?

Direct peers on record are Labconco Corporation, Martin Christ Gefriertrocknungsanlagen GmbH, BÜCHI Labortechnik AG, Telstar (Azbil Corporation), SP Scientific (SP Industries, ATS Corporation), IMA Life (IMA S.p.A.) and Millrock Technology, Inc.. Broad incumbents are GEA Group AG, Hosokawa Micron Group and Thermo Fisher Scientific Inc..

Does LyoWave have an API?

No public API is recorded for LyoWave.

What industry is LyoWave in?

LyoWave's product category is Pharmaceutical Freeze-Drying Equipment. Its primary akta.pro industry code is HLAAAJAG, Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces), with a secondary code of HLAGAIAC, General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens). Its NAICS code is 333414 and its SIC code is 3585.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales